2. ASIA 2 X 27

2. ASIA 2 X 27

Asia vulnerable to U.S.-style
accounting fiascos despite reforms

3. Spore 2 X 20

No quick relief for
fussy Singaporeans

4. Drug 3 X 20

Bristol-Myers, Merck
cases mark struggles
of drug industry